These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
226 related articles for article (PubMed ID: 9427782)
41. [What's new in hormone replacement therapy of postmenopausal women? II. Risks of hormone replacement therapy (HRT)]. Martin-Du Pan RC; Luzuy F Rev Med Suisse Romande; 2000 Jun; 120(6):523-7. PubMed ID: 11014097 [TBL] [Abstract][Full Text] [Related]
42. Hormone therapy and the impact of estrogen intake on the risk of ovarian cancer. Glud E; Kjaer SK; Thomsen BL; Høgdall C; Christensen L; Høgdall E; Bock JE; Blaakaer J Arch Intern Med; 2004 Nov; 164(20):2253-9. PubMed ID: 15534163 [TBL] [Abstract][Full Text] [Related]
43. Hormone replacement therapy and the endometrium. Daayana S; Holland CM Menopause Int; 2009 Sep; 15(3):134-8. PubMed ID: 19723685 [TBL] [Abstract][Full Text] [Related]
44. The World Health Organization defines hormone replacement therapy as carcinogenic: is this plausible? Mueck AO; Seeger H Gynecol Endocrinol; 2008 Mar; 24(3):129-32. PubMed ID: 18335326 [TBL] [Abstract][Full Text] [Related]
45. Progestogen deficiency and endometrial cancer risk. Schindler AE Maturitas; 2009 Apr; 62(4):334-7. PubMed ID: 19231117 [TBL] [Abstract][Full Text] [Related]
46. Vaginal bleeding patterns in women receiving hormone replacement therapy. Impact of various progestogen regimens. Thorneycroft IH; Gibbons WE J Reprod Med; 1999 Feb; 44(2 Suppl):209-14. PubMed ID: 11392034 [TBL] [Abstract][Full Text] [Related]
54. Hormone replacement therapy and endometrial, ovarian and colorectal cancer. Gambacciani M; Monteleone P; Sacco A; Genazzani AR Best Pract Res Clin Endocrinol Metab; 2003 Mar; 17(1):139-47. PubMed ID: 12763517 [TBL] [Abstract][Full Text] [Related]
55. Hormone replacement therapy and breast cancer risk. Gambrell RD S Afr J Surg; 1996 Nov; 34(4):169-73; discussion 173-4. PubMed ID: 9015939 [No Abstract] [Full Text] [Related]
56. Hormone replacement therapy as a risk factor for epithelial ovarian cancer: results of a case-control study. Weber AM Obstet Gynecol; 1997 Oct; 90(4 Pt 1):641-2. PubMed ID: 9380334 [No Abstract] [Full Text] [Related]
57. Effects of hormone replacement therapy on the endometrium and lipid parameters: a review of randomized clinical trials, 1985 to 1995. Pickar JH; Thorneycroft I; Whitehead M Am J Obstet Gynecol; 1998 May; 178(5):1087-99. PubMed ID: 9609589 [TBL] [Abstract][Full Text] [Related]
58. Hormone replacement therapy and the risk of endometrial cancer: A systematic review. Sjögren LL; Mørch LS; Løkkegaard E Maturitas; 2016 Sep; 91():25-35. PubMed ID: 27451318 [TBL] [Abstract][Full Text] [Related]
59. [Cancer prevention]. Mori M; Sagae S Nihon Rinsho; 2004 Oct; 62 Suppl 10():17-21. PubMed ID: 15535199 [No Abstract] [Full Text] [Related]